Previous 10 | Next 10 |
home / stock / orxoy / orxoy news
Orexo's digital therapy deprexis® reimbursed under the US Veterans Affairs Federal Supply Schedule PR Newswire Orexo is granted a Veterans Affairs Federal Supply Schedule contract for deprexis® in the US and will be reimbursed and made available by the federa...
Orexo's nasal adrenaline rescue medication OX640 enters clinical development PR Newswire OX640 has the potential to provide important benefits to patients and healthcare systems ensuring the correct adrenaline dose is both reliably and conveniently available - for the ...
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 23 r d Life Sciences Investor Forum are now available for on-demand viewing. REGISTER NOW OR LOG...
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the agenda for the upcoming Life Sciences Investor Forum to be held on June 23 rd . Individual inve...
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the agenda for the upcoming Life Sciences Investor Forum to be held on June 23 rd . Individual inve...
Orexo AB press release (OTCQX:ORXOY): Q1 GAAP EPS of -SEK 0.69. Revenue of SEK 159.4M (+20.5% Y/Y). For further details see: Orexo AB GAAP EPS of -SEK 0.69, revenue of SEK 159.4M
Orexo Interim Report Q1 2022 PR Newswire UPPSALA, Sweden , April 28, 2022 /PRNewswire/ -- Promising start to 2022 Q1 2022 highlights Total net revenues of SEK 159.4 m (132.3) EBITDA of SEK 2.8 m (-23.9) Net earnin...
Orexo´s partner Gesynta Pharma granted Orphan Drug Designation by the FDA for OX-MPI (GS-248) for the treatment of systemic sclerosis PR Newswire UPPSALA, Sweden , April 27, 2022 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), ann...
Report from Orexo AB's annual general meeting PR Newswire UPPSALA, Sweden , April 21, 2022 /PRNewswire/ -- Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 21 April 2022 resolved, in accordance with t...
Orexo publishes 2021 Annual Report PR Newswire UPPSALA, Sweden , March 31, 2022 /PRNewswire/ -- Orexo's Annual Report for the 2021 has been published. The Annual Report can be downloaded on the company's website, www.orexo.com , and a PDF is...
News, Short Squeeze, Breakout and More Instantly...
Orexo: invitation to presentation of the Q2 2024 Interim Report PR Newswire UPPSALA, Sweden , July 8, 2024 /PRNewswire/ -- As previously communicated Orexo will announce the Interim Report for the second quarter of 2024 on July 17 at 8 am CET . The same ...
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum held June 20 th are now available for online viewing. REGISTER NOW AT : ...
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Virtual Investor Forum to be held on June 20 th , 2024. This event is co-sponsored by Zack’s Small Cap Research. ...